Krishnan Krish S's Form 4 filing
Krystal Biotech, Inc. (KRYS) · filed Jun 2, 2023
- Accession no.
- 0001298709-23-000018
- Filed
- Jun 2, 2023
- Trade date
- May 31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $5.81M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krishnan Krish SCIK 0001298709 | Director, Officer (President and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Common Stock | SSaleDisposed | −18,884 | $116.00F1 | −$2,190,544 | 1,690,454 | Direct | |
| May 31, 2023 | Common Stock | SSaleDisposed | −5,716 | $116.95F2 | −$668,486.2 | 1,684,738 | Direct | |
| May 31, 2023 | Common Stock | SSaleDisposed | −400 | $117.61F3 | −$47,044 | 1,684,338 | Direct | |
| May 31, 2023 | Common Stock | SSaleDisposed | −20,143 | $115.98F1 | −$2,336,185.14 | 1,629,063 | Indirect | |
| May 31, 2023 | Common Stock | SSaleDisposed | −4,557 | $116.86F6 | −$532,531.02 | 1,624,506 | Indirect | |
| May 31, 2023 | Common Stock | SSaleDisposed | −300 | $117.57F7 | −$35,271 | 1,624,206 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The transaction was executed in multiple trades ranging from $115.5200 to $116.5100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F2
The transaction was executed in multiple trades ranging from $116.5200 to $117.5000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F3
The transaction was executed in multiple trades ranging from $117.5500 to $117.7200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F6
The transaction was executed in multiple trades ranging from $116.5200 to $117.5100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F7
The transaction was executed in multiple trades ranging from $117.5500 to $117.6000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.